SEC Form 4 · accession 0001209191-18-061479
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce I Sachs
Director
Period of report
Dec 6, 2018
Accepted (ET)
Dec 7, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2018 | M | 10,000 | $34.24 | A | 23,011 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $34.24 | Dec 6, 2018 | M | 10,000 | D | — | May 31, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Fully vested.